This webinar includes a panel of experts discussing the questions healthcare providers have about using 3 months of isoniazid and rifapentine once weekly (3HP) to treat latent TB infection (LTBI).
This webinar was created for physicians and other licensed medical professionals who diagnose and treat latent tuberculosis infection (LTBI). The webinar focuses on risk assessment, diagnosis, and treatment options for LTBI.
This 60-minute webinar reviews best practices for TB diagnosis and management for ICE detainees, the role of public health and community partners, and how care is coordinated for patients who are released.
The case presentation discussed in this 60-minute webinar provides insight on the complicated factors a nurse case manager navigated to treat a patient with disseminated TB. The webinar was created for TB nurses, nurse case managers, and public health nurses who manage TB patients.
Presented on September 21, 2021 by the TB Centers of Excellence and the Centers for Disease Control and Prevention
This 90-minute webinar focuses on how anti-black racism impacts African Americans' access to care and the quality of care they receive. The webinar also includes information on specific strategies for clinicians and programs to consider to improve TB care for African American patients.
This 90-minute webinar was held for clinicians and others who provide services to TB patients or persons at risk for TB with significant alcohol and/or tobacco use.
In this 40-minute webinar, participants learn about TB basics, testing, and diagnosis. Participants also receive information on TB related guidelines in Indiana for the long term care setting for both residents and staff.
In this webinar, Dr. Drew Posey shares knowledge on the US TB screening program. The webinar includes information on how US-bound immigrants and refugees are screened for TB, the effect of the screening program on US TB efforts, and how information from the overseas exam is transmitted.
In this webinar, Dr. Charles Peloquin presents information on the epidemiology of TB in the US. Dr. Peloquin also discusses emerging treatments for latent TB infection and for active TB disease.